Board of Directors

Daniel R. Frank

Mr. Frank started his investment career in 1979 as an analyst with Fidelity Management and Research "Fidelity Investments". In 1981, he became an assistant to Peter Lynch on Fidelity Magellan Fund, and in 1982, he formally launched his own fund "Fidelity Special Situations/Strategic Opportunities Fund" which grew to over $800 million. For the past decade Mr. Frank was a Managing Director at Cerberus Capital Management responsible for healthcare related investments, in both the public and private markets, from start-ups to established businesses in need of growth capital. In this role, he served as lead investor, co-investor, and various roles on the Board of Directors of the respective investments. The areas of focus encompassed diagnostics, specialty pharmaceuticals and medical devices.

Robert T. Leonard

Mr. Leonard is Glytec's CEO and also serves on the Board of Directors. Mr. Leonard has over 25 years' experience in healthcare in various general management, senior sales and marketing positions. His experience encompasses information technology, hospital information systems, point-of-care devices, disease management and alternate site services; all relevant to the composition of Glytec's unique offering. Previous employers include, PatientKeeper, provider of physician healthcare information systems, which grew from zero to 450 hospital clients during his tenure; McKesson Information Systems, FluidSense (IV /fluid management) and Chartwell, a series of academic medical center partnerships focused on alternate site care. Mr. Leonard has a proven track record of developing and leading high quality, high performance teams in fast growth companies. In his present role, as in several previous, he is responsible for developing and implementing the strategic vision of the company and more importantly, ensuring the company's culture is driven by an unwavering focus on the success and improved health of the hospitals and patients it was created to serve.

Patrick F. Cua

Mr. Cua has thirty years of healthcare leadership experience ranging from large Fortune 500 companies to startups focused on solutions for hospitals and health plans. Mr. Cua’s industry experience began with C.R. Bard and has included executive leadership positions with CorSolutions, Matria Healthcare, Aetna and Alere. Mr. Cua currently serves as President of HSG Partners. In addition to serving on the Glytec Board of Directors, Mr. Cua also serves on the Board of Directors of several other successful, high-growth healthcare technology companies, including BioIQ in Santa Barbara, California, and GozioHealth in Atlanta, Georgia.

Jay Fleischman, MD

Dr. Fleischman is Clinical Associate Professor of Ophthalmology at Albert Einstein College of Medicine. He was a systems analyst/programmer at New York’s NASA Goddard Institute for Space Studies while he completed his applied math/computer engineering and then medical degrees at Columbia University. He completed his ophthalmology training at the Wilmer Institute, Johns Hopkins and his retina specialty training at the Medical College of Wisconsin. In 1980, Dr. Fleischman became the Director of Retina at the Bethesda Eye Institute, St. Louis University and then served as Director at Montefiore Hospital, Albert Einstein College of Medicine to New York in 1988. Since 1984, Dr. Fleischman has lectured and taught surgery around the world through Project ORBIS (the Flying Eye Hospital), has authored many papers, and holds patents, one pending on a device that will help restore vision to patients with macular degeneration, the leading cause of vision loss after age 55. Of the many surgical devices Dr. Fleischman has invented, the laser endophotocoagulator has become an indispensable tool and a worldwide “standard of care” for advanced surgical retina cases. An expert in diabetes treatment and its complications, in particular diabetic retinopathy, he served as an investigator in The Diabetes Control and Complications Trial (DCCT), a landmark medical study conducted by the US National Institute of Diabetes and Digestive and Kidney Diseases. Dr. Fleischman has consulted for many companies including HGM, Alcon and Mentor and served as an advisor for Dauphin Capital Management and NGN Capital Management. As a Pfizer medical advisor at their Hospital Products Division, he helped them evaluate many innovative medical devices and surgical instruments which served to increase the 1998 sale value of that division. He now serves as an FDA medical device panel member.

C. Edward Floyd, MD

Dr. Floyd is a general and vascular surgeon with over 50 years of experience. He is currently a Clinical Professor of Surgery at University of South Carolina Medical School, Columbia, South Carolina, and a Clinical Professor of Surgery at MUSC Medical School, Charleston, South Carolina. He was the President and Founder of Floyd Medical Associates, PA; Vascular Laboratory of Florence, Incorporated; Floyd Farms; and Tan Bays Farms. He was also co-owner of Floyd Motor Company in Lake City, South Carolina. Dr. Floyd graduated from University of South Carolina and the Medical College of South Carolina in Charleston. He completed his internship and residency at Charity Hospital in New Orleans, Louisiana, then he returned to Florence, South Carolina to open his surgical practice. In addition to being a member of nine medical societies, Dr. Floyd exemplifies the qualities of leadership and service. He is active in his community and serves on numerous boards and committees, including the University of South Carolina (past Chairman), Carolinas Hospital System (Chairman), and National Bank of South Carolina, Drs. Bruce and Lee Foundation (Chairman). Additionally, he has served on Orthopaedic Research Foundation for the Carolinas, Florence General Hospital, Synovus Financial Corporation, Quorum Health Group, South Carolina Governor’s School for Science and Mathematics Foundation, The Palmetto Conservation Foundation, Irix Pharmaccuticals, the Health Care Leadership Council in Washington, DC, the National Committee on Foreign Medical Education, and as a Delegate to the United Nations General Assembly. Dr. Floyd was recognized as a Distinguished Eagle Scout and the 2006 Florence Chamber of Commerce Business Person of the Year. He received honorary doctoral degrees from Francis Marion University and University of South Carolina, and he received the Order of the Palmetto in 1996. In 1995, he was chosen as one of 50 physicians nationwide for Positive Medicine.

Paul Fulchino

Mr. Fulchino's experience spans 46 years as a business executive and strategic advisor to senior management. He has demonstrated a consistent record of achievement in his roles as Partner of Aeroequity (2017-Present), one of the leading private equity firms; Senior Advisor to the Boeing Company (2010-2014); President and Chief Executive Officer of Aviall, Inc. (1999-2010), the world's largest aircraft parts Service Provider; President and Chief Operating Officer of B/E Aerospace (1996-1999), the largest aircraft interiors manufacturer; and President and Vice Chairman of Mercer Management Consulting (now Oliver Wyman Associates) (1976-1996), one of the leading international consulting firms. In each of these entities, Mr. Fulchino led the organizations to double digit annual growth in revenues and profitability. In addition to his public and private company leadership roles, Mr. Fulchino serves on Boards of several for-profits, including Spirit Aerosystems, Wesco Aircraft, Kellstrom Aerospace, Belcan Corporation and Global Technology Systems, as well as non-profits, such as Boston College. His notable prior Board roles include The Sports Authority, Medsource Technologies and Mercer Consulting. Mr. Fulchino attended the United States Military Academy, received an A.B. in mathematics from Boston College, and earned his M.B.A. from Columbia University Graduate School of Business with a concentration in finance and operations research.

Andrew Midler

Mr. Midler serves as Managing Member at Savitr Capital, LLC which has its primary focus in health care venture investments. Mr. Midler founded the firm in 2008. Previously, Mr. Midler served as the Chief Executive Officer and Chief Investment Officer at Standard Pacific Capital. From 1986 to 1993, he worked as a Portfolio Manager at Fidelity Investments. Mr. Midler holds an M.B.A. from Harvard Business School. He earned M.A. and B.A. degrees in Political Science from Stanford University.

Lynn Vogel, PhD

Dr. Vogel has served as VP and CIO at academic medical centers throughout his career, including University of Texas MD Anderson Cancer Center in Houston, Texas, The University of Chicago Hospitals, and Mount Sinai Medical Center and New York Presbyterian Healthcare in New York City. He has also served as a faculty member in Biomedical Informatics (at Columbia University-New York City) and Bioinformatics/Computational Biology (at MD Anderson). For several years, Dr. Vogel served on the National Cancer Institute's National Cancer Advisory Board Informatics Working Group and was a Member and Fellow (FHIMSS) of the Healthcare Information Management Systems Society (HIMSS).  He continues as a Fellow (FCHIME) and Life Fellow (LCHIME) of the College of Healthcare Information Management Executives (CHIME), where he was a Charter Member, and previously served as Board Member and Board Chair and was a faculty member of the CHIME CIO Boot Camp. He is also a long standing member of the American Medical Informatics Association (AMIA). Dr. Vogel is currently affiliated with Next Wave Health Advisors and consults through his own firm, LH Vogel Consulting LLC. Dr. Vogel's education at the bachelor's, masters and doctoral level was completed at The University of Chicago.

Request Demo